• Poster

Lapatinib Plus Paclitaxel Versus Paclitaxel Alone for First-Line Metastatic Breast Cancer in ErbB2-Positive Patients: Quality-of-Life Results

Citation

Wu, Y., Segreti, A., Cella, D., DiLeo, A., Amonkar, M. M., Koehler, M., ... Walker, M. D. (2008, April). Lapatinib Plus Paclitaxel Versus Paclitaxel Alone for First-Line Metastatic Breast Cancer in ErbB2-Positive Patients: Quality-of-Life Results. Presented at 6th European Breast Cancer Conference, .

Abstract